Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells

被引:54
作者
Nakano, M. [2 ,3 ]
Fujii, T. [1 ,2 ]
Hashimoto, M.
Yukawa, N. [2 ]
Yoshifuji, H. [2 ]
Ohmura, K. [2 ]
Nakaizumi, A. [3 ]
Mimori, T. [2 ]
机构
[1] Kyoto Univ, Dept Control Rheumat Dis, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Rheumatol & Clin Immunol, Grad Sch Med, Kyoto 6068507, Japan
[3] Kyoto Univ, Dept Appl Lab Sci, Grad Sch Med, Kyoto 6068507, Japan
关键词
CCL5 (RANTES); connective tissue disease; CX3CL1 (fractalkine); pulmonary vascular disease; type I interferon; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARTERIAL-HYPERTENSION; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; CHEMOKINE; EXPRESSION; RECEPTOR; BETA; MANIFESTATIONS; ACTIVATION;
D O I
10.1111/j.1365-2249.2012.04638.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type I interferon (IFN) medications cause various adverse reactions, including vascular diseases. Although an association between chemokines and vascular diseases has also been reported, the relationship between type I IFN and chemokines in vascular endothelial cells (VEC) remains unclear. To provide clues to pathogenesis of the diseases, we analysed the effects of type I IFN on chemokine production in human VEC. Type I IFN induced higher CX3CL1 (fractalkine) mRNA expression and protein secretion in pulmonary arterial VEC than in umbilical vein VEC. Type I IFN also induced CCL5 [regulated upon activation normal T cell expressed and secreted (RANTES)] production in VEC, especially in lung micro-VEC. IFN-beta induced much higher chemokine production than IFN-a, and Janus protein tyrosine kinase (JAK) inhibitor I prevented type I IFN-induced chemokine secretion. Type I IFN-induced chemokines may be involved in the pathophysiology of pulmonary vascular diseases, and the JAK inhibitor may serve as a therapeutic option for these diseases.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 40 条
[1]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[2]   Fractalkine preferentially mediates arrest and migration of CD16+ monocytes [J].
Ancuta, P ;
Rao, R ;
Moses, A ;
Mehle, A ;
Shaw, SK ;
Luscinskas, FW ;
Gabuzda, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) :1701-1707
[3]   CX3C chemokine fractalkine in pulmonary arterial hypertension [J].
Balabanian, K ;
Foussat, A ;
Dorfmüller, P ;
Durand-Gasselin, I ;
Capel, F ;
Bouchet-Delbos, L ;
Portier, A ;
Marfaing-Koka, A ;
Krzysiek, R ;
Rimaniol, AC ;
Simonneau, G ;
Emilie, D ;
Humbert, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (10) :1419-1425
[4]   A new class of membrane-bound chemokine with a CX(3)C motif [J].
Bazan, JF ;
Bacon, KB ;
Hardiman, G ;
Wang, W ;
Soo, K ;
Rossi, D ;
Greaves, DR ;
Zlotnik, A ;
Schall, TJ .
NATURE, 1997, 385 (6617) :640-644
[5]   The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF [J].
Belge, KU ;
Dayyani, F ;
Horelt, A ;
Siedlar, M ;
Frankenberger, M ;
Frankenberger, B ;
Espevik, T ;
Ziegler-Heitbrock, L .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3536-3542
[6]   Interferons at age 50: past, current and future impact on biomedicine [J].
Borden, Ernest C. ;
Sen, Ganes C. ;
Uze, Gilles ;
Silverman, Robert H. ;
Ransohoff, Richard M. ;
Foster, Graham R. ;
Stark, George R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (12) :975-990
[7]   Subcutaneous Interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction [J].
Buttmann, M ;
Goebeler, M ;
Toksoy, A ;
Schmid, S ;
Graf, W ;
Berberich-Siebelt, F ;
Rieckmann, P .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 168 (1-2) :175-182
[8]   Fractalkine (CX3CL1) stimulated by nuclear factor κB (NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway [J].
Chandrasekar, B ;
Mummidi, S ;
Perla, RP ;
Bysani, S ;
Dulin, NO ;
Liu, F ;
Melby, PC .
BIOCHEMICAL JOURNAL, 2003, 373 :547-558
[9]   Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C [J].
Dhillon, Sonu ;
Kaker, Anshul ;
Dosanjh, Aneil ;
Japra, Deepa ;
VanThiel, David H. .
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (06) :1785-1790
[10]   Chemokine RANTES in severe pulmonary arterial hypertension [J].
Dorfmüller, P ;
Zarka, V ;
Durand-Gasselin, I ;
Monti, G ;
Balabanian, K ;
Garcia, G ;
Capron, F ;
Coulomb-Lherminé, A ;
Marfaing-Koka, A ;
Simonneau, G ;
Emilie, D ;
Humbert, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (04) :534-539